We found that IL-1β treatment increased Pmel-1 cell numbers only in the tumor but enhanced Gzm B expression in both the tumor-draining LNs and tumor (Fig. 1, C and D), consistent with the OT-I findings (Fig. 1, A and B). The gene discussed is IL1B; the disease is neoplasm.